Allogene Therapeutics, Inc. valuation and forecast
Explore the models for Allogene Therapeutics, Inc., adjust their assumptions and compare your own valuation with the platform's.
Stock price today
Loading chart…
Third-party market data · may be delayed
Fair value per share
Under review: data-quality checks not passed.
Price vs value
Under review: data-quality checks not passed. We'll show the comparison once resolved.
Analyst recommendations
Monthly trend
- Oct 202612
- Sep 202612
- Aug 202612
- Jul 202612
Counts of recommendations published by analysts covering Allogene Therapeutics, Inc., by month. Source: Aggregated broker recommendations (third-party data). Aggregated counts only: we do not reproduce any firm's recommendation or price target, and these are not Fundamentalytics ratings.
Price history
Loading chart…
Third-party market data · may be delayed
ALLO valuation questions
- How does Fundamentalytics value Allogene Therapeutics, Inc.?
- We use the models that fit Allogene Therapeutics, Inc.'s business and available financial data: growth cash-flow model. Each model has its own assumptions and data requirements. The calculator explains which models are available and lets you adjust their inputs.
Data: SEC EDGAR filings, retrieved November 1, 2026. Method: how we value companies. Disclosures: research and recommendations disclosure. Back to Allogene Therapeutics, Inc.